A new validation study on the prognostic performance of Stratipath Breast.
19 August 2024
Stratipath is excited to announce the publication of a new
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Stratipath is excited to announce the publication of a new
Swelife conducted an interview with our Chief Medical Officer and
Stratipath was honored with the Dream Award at the Techarenan
Seminar – Almedalen. ”AI can predict relapse in breast cancer
Seminar – Almedalen ”No precision medicine without pathology”
Stratipath Breast, is now officially registered with the Medicines and
Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic
Stratipath is happy to announce that one of the most
Swelife conducted an interview with our Chief Medical Officer and
Stratipath co-founder Professor Johan Hartman, is discussing the future of